Autumn Glory Partners’s Bristol-Myers Squibb BMY Stock Holding History

Autumn Glory Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$449K	Buy	+7,410	New	+$432K	0.17%	133
2025 Q1	–	Sell	-4,001	Closed	-$226K	–	177
2024 Q4	$226K	Sell	4,001 -68	-2%	-$3.8K	0.11%	160
2024 Q3	$211K	Buy	+4,069	New	+$191K	0.08%	193
2022 Q3	–	Sell	-3,293	Closed	-$254K	–	154
2022 Q2	$254K	Hold	3,293	–	–	0.19%	115
2022 Q1	$240K	Sell	3,293 -368	-10%	-$24.7K	0.14%	136
2021 Q4	$228K	Buy	+3,661	New	+$215K	0.1%	190

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Autumn Glory Partners's BMY Position: Q1 2026 in Review

Autumn Glory Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 7,410 shares worth $449K. The stake represents 0.17% of the portfolio and ranks #133 among its holdings. This is a return to the name: Autumn Glory Partners previously reported a position in BMY as recently as Q4 2024.

Autumn Glory Partners first reported a position in BMY in Q4 2021 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Autumn Glory Partners held 7,410 shares of Bristol-Myers Squibb worth $449K as of Q1 2026.
Bristol-Myers Squibb was a new Autumn Glory Partners position in Q1 2026.
Bristol-Myers Squibb made up 0.17% of Autumn Glory Partners's portfolio in Q1 2026, its #133 holding.
Autumn Glory Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 6 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Autumn Glory Partners's 13F filing for Q1 2026, filed 4 May 2026.